[A rare tumour with a distinctive histological appearance].
Pavageau
Aude-Hélène
AH
UF d'histopathologie-cytopathologie, département de pathologie cellulaire et tissulaire, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France. audehelene3@hotmail.com
Croué
Anne
A
Reguerre
Yves
Y
Rialland
Xavier
X
Rousselet
Marie-Christine
MC
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001165:Arteriovenous Malformations / Q000175:diagnosis; D000068258:Bevacizumab; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D003609:Dactinomycin / Q000008:administration & dosage; D003893:Desmin / Q000032:analysis; D003937:Diagnosis, Differential; D004149:Dioxoles / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007866:Leg / Q000473:pathology*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis; D011379:Prognosis; D009418:S100 Proteins / Q000032:analysis; D018234:Sarcoma, Alveolar Soft Part / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology* / Q000556:secondary / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D013194:Staining and Labeling; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage; D000077606:Trabectedin; D014750:Vincristine / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D003893:Desmin; D004149:Dioxoles; D009363:Neoplasm Proteins; D009418:S100 Proteins; D044005:Tetrahydroisoquinolines; D003609:Dactinomycin; D000068258:Bevacizumab; D014750:Vincristine; D004317:Doxorubicin; D000077606:Trabectedin; D007069:Ifosfamide